| 000 | 00969nam a2200253Ia 4500 | ||
|---|---|---|---|
| 003 | OSt | ||
| 005 | 20260806120221.0 | ||
| 008 | 210219s9999||||xx |||||||||||||| ||und|| | ||
| 020 | _a9789351072720 | ||
| 082 | _a615.19 SIL-O | ||
| 100 |
_aSilverman, Richard B. _922508 |
||
| 245 | 0 | _aOrganic chemistry of drug design and drug action | |
| 250 | _a3rd ed | ||
| 260 |
_aNew Delhi _bElsevier _c2017 |
||
| 300 | _axviii, 517 pages : illustrations (some color) ; 29 cm | ||
| 505 | _aIntroduction -- Lead discovery and lead modification -- Receptors -- Enzymes -- Enzyme inhibition and inactivation -- Dna-interactive agents -- Drug resistance and drug synergism -- Drug metabolism -- Prodrugs and drug delivery systems | ||
| 650 |
_aPharmaceutical chemistry _992841 |
||
| 650 |
_a Bioorganic chemistry _992842 |
||
| 650 |
_a Molecular pharmacology _992843 |
||
| 650 |
_a Drugs--Design _992844 |
||
| 700 |
_aHolladay, Mark W _992845 |
||
| 942 | _cBK | ||
| 999 |
_c57169 _d57169 |
||